LAUREN BARRERA: Open Payments
NPI 1689076549 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$973 in 50 payments from 19 companies in 2025. Trend: 2023 $1,630 · 2024 $922 · 2025 $973
Food & beverage: $973
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $214 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $142 |
| PFIZER INC. | 4 | $86 |
| Otsuka America Pharmaceutical, Inc. | 1 | $82 |
| Novo Nordisk Inc | 4 | $72 |
| Lundbeck LLC | 3 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Verity Pharmaceuticals Inc. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
Products named: Kerendia, REXULTI, QULIPTA, UBRELVY, LEQVIO, ELIQUIS, TRELEGY ELLIPTA, NURTEC ODT.
Industry payments across TX — which companies pay providers there.
